Predictors of mortality in insulin dependent diabetes; 10 year observational follow up study

British Medical Journal

Volumn 313, Issue 7060, 1996, Pages 779-784

  Rossing, Peter ^a   Hougaard, Philip ^b   Borch Johnsen, Knut ^c   Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; ARTICLE; CAUSE OF DEATH; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HEIGHT; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; OUTPATIENT; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; SOCIAL CLASS; SURVIVAL; URINARY EXCRETION;

EID: 0029816538     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7060.779     Document Type: Article

References (39)

1. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985;28:590-6.
2. Parving H-H, Oxenbøll B, Svendsen PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. Acta Endocrinol 1982;100:550-5.
3. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i:1430-2.
4. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
5. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984;310:356-60.
6. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Risk factors for development of micro- and macroalbuminuria in non-insulin-dependent diabetes mellitus. Diabetologia 1995;38(suppl 1):A215.
7. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984;1:17-9.
8. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in XIDDM. Diabetes 1995;44:1303-9.
9. Messent J, Elliott T, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992;41:836-9.
10. Pedersen MM, Christensen CK, Mogensen CE. Long-term (18 year) prognosis for normo- and microalbuminuria type 1 (insulin-dependent) diabetic patients. Diabetologia 1992;35:A60.
11. Parving H-H, Hommel E, Mathiesen ER, Skøtt P, Edsberg B, Bahnsen M, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes. BMJ 1988;296:156-60.
12. Mogensen CE, Chachati A, Christensen CK, Close CF, Decken T, Hommel E, et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985;9:85-95.
13. Hansen EJ. The distribution of living conditions in Denmark. Copenhagen: Teknisk Forlag, 1982:1-102.
14. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
15. Andersen PK, Borgan Ø, Gill R, Keiding NR. Left truncation; smoothing the Nelson-Aalen estimator; regression models. In: Statistical models based on counting processes. New York: Springer, 1993;152-61;229-55;476-588.
16. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty one, I. Survival, causes of death and complications. Diabetologia 1978;14:363-70.
17. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-5.
18. Moss SE, Klein R, Klein BEK, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994;154:2473-9.
19. Parving H-H, Hommel E. Prognosis in diabetic nephropathy. BMJ 1989;299:230-3.
20. Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia 1989;32:884-6.
21. Parving H-H, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P. Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int 1996;49:1778-82.
22. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 1987;294:1651-4.
23. Forsblom CM, Groop P-H, Ekstrand A, Groop L. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ 1992;305:1051-3.
24. Parving H-H, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy. In: Brenner BM, ed. The Kidney. Philadelphia: Saunders, 1996:1864-92.
25. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991;34:164-70.
26. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
27. Microalbuminuria Collaborative Study Group, United Kingdom. Intensive therapy and progressive to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. BMJ 1995;311:973-7.
28. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9.
29. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. BMJ 1991;303:81-7.
30. Viberti GC, Mogensen CE, Groop L, Pauls JF, European Microalbuminuria Captopril Study Group. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-9.
31. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for microalbuminuria worth while in patients with insulin dependent diabetes. BMJ 1993;306:1722-5.
32. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983;25:496-501.
33. Knowles HCJ. Long term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians 1971;84:95-101.
34. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type 1 diabetes. Am J Med 1985;78:785-94.
35. Sawicki PT, Mühlhauser I, Didjurgeit U, Baumgartner A, Bender R, Berger M. Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens 1995;13:933-8.
36. Marmot MG, Shepley MJ, Rose G. Inequalities in death - specific explanations of a general pattern? Lancet 1984;i:1003-6.
37. Herbert PR, Rich-Edwards JW, Manson JE, Ridker PM, Cook NR, O'Connor GT, et al. Height and incidence of cardiovascular disease in male physicians. Circulation 1993;88:1437-43.
38. Rossing P, Tarnow L, Nielsen FS, Boelskifte S, Brenner BM, Parving H-H. Short stature and diabetic nephropathy. BMJ 1995;310:296-7.
39. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP. Microalbuminuria: associations with height and sex in non-diabetic subjects. BMJ 1993;306:240-2.